Wu Huizhe について
Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China について
Wu Huizhe について
Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer... について
Qin Wenyan について
Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China について
Qin Wenyan について
Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer... について
Lu Senxu について
Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China について
Lu Senxu について
Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer... について
Wang Xiufang について
Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China について
Wang Xiufang について
Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer... について
Zhang Jing について
Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China について
Zhang Jing について
Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer... について
Sun Tong について
Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China について
Sun Tong について
Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer... について
Hu Xiaoyun について
Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China について
Hu Xiaoyun について
Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer... について
Li Yalun について
Department of Anorectal Surgery, First Hospital of China Medical University, Shenyang, People’s Republic of China について
Chen Qiuchen について
Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China について
Chen Qiuchen について
Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer... について
Wang Yuanhe について
Department of Medical Oncology, Cancer Hospital of China Medical University, Shenyang, People’s Republic of China について
Zhao Haishan について
Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China について
Zhao Haishan について
Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer... について
Piao Haiyan について
Department of Medical Oncology, Cancer Hospital of China Medical University, Shenyang, People’s Republic of China について
Zhang Rui について
Department of Medical Oncology, Cancer Hospital of China Medical University, Shenyang, People’s Republic of China について
Wei Minjie について
Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, People’s Republic of China について
Wei Minjie について
Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation; Liaoning Cancer immune peptide drug Engineering Technology Research Center; Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical Univer... について
Molecular Cancer (Web) について
蛍光 について
メチル化 について
RNA【核酸】 について
遺伝子 について
タンパク質 について
細胞増殖 について
in vitro実験 について
アポトーシス について
ウェスタンブロット法 について
腫瘤形成 について
DNAマイクロアレイ について
遺伝子サイレンシング について
snoRNA について
バイオインフォマティクス について
過剰発現 について
ZFAS1 について
SNORD12C について
SNORD78 について
2π-O-メチル化(2π-O-me) について
NOP58 について
大腸癌(CRC) について
遺伝子発現 について
結腸直腸癌 について
RNA について
仲介 について
メチル化 について
促進 について
長鎖非コードRNA について